These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11277206)

  • 41. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
    Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphometric and histopathologic analysis of lymphoid depletion in murine spleens following infection with Brucella abortus strains 2308 or RB51 or an htrA deletion mutant.
    Palmer MV; Cheville NF; Tatum FM
    Vet Pathol; 1996 May; 33(3):282-9. PubMed ID: 8740701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison between immune responses and resistance induced in BALB/c mice vaccinated with RB51 and Rev. 1 vaccines and challenged with Brucella melitensis bv. 3.
    Hamdy ME; El-Gibaly SM; Montasser AM
    Vet Microbiol; 2002 Aug; 88(1):85-94. PubMed ID: 12119140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pregnant mouse model for the vertical transmission of Brucella melitensis.
    Wang Z; Wang SS; Wang GL; Wu TL; Lv YL; Wu QM
    Vet J; 2014 Apr; 200(1):116-21. PubMed ID: 24462801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporal analysis of pathogenic events in virulent and avirulent Brucella melitensis infections.
    Rajashekara G; Glover DA; Krepps M; Splitter GA
    Cell Microbiol; 2005 Oct; 7(10):1459-73. PubMed ID: 16153245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluating the virulence of a Brucella melitensis hemagglutinin gene in the caprine model.
    Perry QL; Hagius SD; Walker JV; Elzer PH
    Vaccine; 2010 Oct; 28 Suppl 5():F6-11. PubMed ID: 20362205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Large-scale identification of small noncoding RNA with strand-specific deep sequencing and characterization of a novel virulence-related sRNA in Brucella melitensis.
    Zhong Z; Xu X; Li X; Liu S; Lei S; Yang M; Yu J; Yuan J; Ke Y; Du X; Wang Z; Ren Z; Peng G; Wang Y; Chen Z
    Sci Rep; 2016 Apr; 6():25123. PubMed ID: 27112796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
    Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R; Francia M; Ciuchini F
    Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen.
    Machelart A; Khadrawi A; Demars A; Willemart K; De Trez C; Letesson JJ; Muraille E
    Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28808159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathogenicity and protective activity in pregnant goats of a Brucella melitensis Deltaomp25 deletion mutant.
    Edmonds MD; Cloeckaert A; Hagius SD; Samartino LE; Fulton WT; Walker JV; Enright FM; Booth NJ; Elzer PH
    Res Vet Sci; 2002 Jun; 72(3):235-9. PubMed ID: 12076120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice.
    Al-Mariri A; Mahmoud NH; Hammoud R
    Biologicals; 2012 Mar; 40(2):140-5. PubMed ID: 22296786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic and splenic immune response during acute vs. chronic Brucella melitensis infection using in situ microscopy.
    Daggett J; Rogers A; Harms J; Splitter GA; Durward-Diioia M
    Comp Immunol Microbiol Infect Dis; 2020 Dec; 73():101490. PubMed ID: 33068875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
    Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
    Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of Brucella melitensis 16M genes required for bacterial survival in the caprine host.
    Zygmunt MS; Hagius SD; Walker JV; Elzer PH
    Microbes Infect; 2006; 8(14-15):2849-54. PubMed ID: 17090391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Osteoarticular tissue infection and development of skeletal pathology in murine brucellosis.
    Magnani DM; Lyons ET; Forde TS; Shekhani MT; Adarichev VA; Splitter GA
    Dis Model Mech; 2013 May; 6(3):811-8. PubMed ID: 23519029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
    Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J
    Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a Brucella melitensis mutant deficient in O-polysaccharide export system ATP-binding protein as a rough vaccine candidate.
    Wang Z; Niu JR; Wang XL; Wu TL; Cheng J; Lu L; Wu QM
    Microbes Infect; 2014 Aug; 16(8):633-9. PubMed ID: 25043564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Production and characterisation of monoclonal antibodies to Brucella melitensis cytosoluble proteins that are able to differentiate antibody responses of infected sheep from Rev. 1 vaccinated sheep.
    Cloeckaert A; Debbarh HS; Zygmunt MS; Dubray G
    J Med Microbiol; 1996 Sep; 45(3):206-13. PubMed ID: 8810948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.